Researchers hope to bring MRI biomarker to dementia risk stratification in patient care, clinical trials Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content contributed by Will Sansom SAN ANTONIO, Jan. 22, 2024 — A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to […]
Locked-in state named Conrad Syndrome after San Antonio survivor Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content contributed by Will Sansom SAN ANTONIO, Jan. 24, 2024 — It is a far cry from the traditionally thought-of “vegetative state” in which the mind is absent while the body lives on. Indeed, it is the opposite. Children with […]
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
The University of Texas Health Science Center at San Antonio was mentioned in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More
Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article. Read More